METHOD FOR DIAGNOSING GALLBLADDER CHOLESTEROSIS

FIELD: medicine. ^ SUBSTANCE: method involves carrying out sonographic examination for detecting inclusions available in cystic bile, evaluating contractile gallbladder function; biochemical study for determining bile lithogenicity properties and blood lipid composition; morphological study for examining mucous and submucous layer cells. When detecting hyperechogenic particles suspension, bile inhomogeneity, ointment-like bile, availability of internal granulated mucous membrane lining in the gallbladder, high echogenicity and gallbladder wall thickening by 1-2 mm, availability of non-movable parietal neoplasms of high echogenicity having granulated outline and structure, gallbladder bile release fraction being equal to or less than 36.6% and bile saturation with cholesterol index being equal to or greater than 1.02 and general blood cholesterol level being equal to or greater than 5.8 mmole/l, high density lipoproteins cholesterol equal to or less than 1.1 mmole/l, low density lipoproteins cholesterol equal to or greater than 3.8 mmole/l, triglycerides equal to or greater than 1.4 mmole/l as well as foam cells being found in the mucous membrane and submucous layer of the gallbladder and epithelium dystrophy being available and de-epithelialization sites on separate fibers being found, gallbladder cholesterosis is to be diagnosed. ^ EFFECT: high accuracy of diagnosis.